Cellix Bio Pvt Ltd. is a biopharmaceutical company, which engages in the development and discovery of novel drugs. It specializes in the treatment of neurology, dermatology, gastrointestinal, inflammation, metabolic and life style, oncology, ophthalmology, and infectious diseases. The company was founded by Mahesh Kandula on May 21, 2014 and is headquartered in Hyderabad, India.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

NATCO Pharma Ltd. engages in the business of pharmaceuticals with research, manufacturing and marketing of finished dosage formulations and active pharmaceutical ingredients. It operates through the following segments: Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients. The Domestic Formulations segment operates in the divisions of oncology, pharma specialties and CnD. The International Formulations segment exports its FDF products from India to several international geographies either through its local partners or directly through its subsidiaries such as in Canada and Brazil. The Active Pharmaceutical Ingredients segment is strategically important as it develops APIs for the captive consumption of many of NATCO's critical FDF products in addition to supplying to direct customers. The company was founded by Venkaiah Chowdary Nannapaneni in 1981 and is headquartered in Hyderabad, India.

Part of Jazz Pharmaceuticals Plc, GW Research Ltd. is a company headquartered in Cambridge, UK. The firm engages in researching and developing biotechnology. It was founded in 1995.

Pharnext is an advanced clinical-stage biopharmaceutical company founded in April 2007 by renowned scientists and entrepreneurs including Professor Daniel Cohen and collaborators, pioneers in modern genomics. The company develops new therapeutics for neurodegenerative diseases - orphan and common – where there are currently no cures and existing therapies available. Pharnext is the pioneer of a new paradigm for the discovery of medicinal drugs: PLEOTHERAPY™. The R&D approach protected by Pharnext systemizes new uses of approved drugs. It is based on network pharmacology utilizing complex and extensive genomic data to identify the thousands of molecules possibly involved in a disease. From this disease molecular network, Pharnext deduces synergistic combinations of drugs already approved but for unrelated indications. These novel therapeutics called PLEODRUG™ are then developed at new optimal doses and under new formulations. They offer several key advantages: efficacy, safety, and intellectual property including several composition of matter patents already granted. The proof of concept of the PLEOTHERAPY approach was obtained with PLEODRUG PXT3003 in Charcot-Marie-Tooth disease type 1A (CMT1A) through positive and consistent Phase 2 and Phase 3 results. PLEODRUG PXT864 generated encouraging Phase 2 data in Alzheimer’s disease. They also plan to develop the same agent in other orphan and common neurodegenerative diseases such as Parkinson’s disease and amyotrophic lateral sclerosis (ALS).

Taisho Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following divisions: Self-Medication, Prescription Pharmaceutical and Overseas Development. The Self-Medication division deals with the research, development, and production of over-the-counter (OTC) drugs, medical supplies, food for specific health use, and hygiene products. The Prescription Pharmaceutical division handles research and development of new drugs in the fields of central nervous system diseases, metabolic diseases, infectious diseases, and inflammatory diseases. The Overseas Development division markets energy drinks and OTC pharmaceuticals overseas. The company was founded on October 12, 1912 and is headquartered in Tokyo, Japan.

Venturepharma, Inc. manufactures pharmaceutical products. It offers VP discovery, API development and outsourcing, biopharmaceuticals discovery, RX and OTC. The firm provides products for oncology, CNS, dermnova, diabetes, cardiovascular, respiration and vaccine. The company was founded in 1998 and is headquartered in Haidian, China.

Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

Colgate-Palmolive Company (Colgate) is a consumer products company whose products are marketed in over 200 countries and territories throughout the world. It operates in two segments: Oral, Personal and Home Care and Pet Nutrition. Oral Care business products include Colgate Total, Colgate Sensitive Pro-Relief, Colgate Max Fresh, Colgate Optic White, and Colgate Luminous White toothpastes, Colgate 360° manual toothbrushes and Colgate and Colgate Plax mouth rinses. Colgate's Oral Care business also includes dental floss and pharmaceutical products for dentists and oral health professionals. Its Personal Care products also include Palmolive, Softsoap and Sanex brand shower gels, Palmolive, Irish Spring, and Protex bar soaps and Speed Stick, Lady Speed Stick and Sanex deodorants and antiperspirants. It sells liquid hand soap under the Palmolive, Protex and Softsoap brands. Colgate, through its Hill's Pet Nutrition segment (Hill's), manufactures pet nutrition products for dogs and cats.

Tianjin Shengji Group Co., Ltd., established on 1998-10-21, Business scope includes technical services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Veterinary drug business;Disinfectant sales(Free of Hazardous Chemicals);Animal Husbandry and Fishery Feed Sales;Feed Additive Sales;fertilizer sales;Retailing of protective equipment for healthcare workers;Pet Food and Supplies Wholesale;Feed production special equipment sales;Refrigeration,Air Conditioning Equipment Sales;road freight transport(Does not contain dangerous goods)Non-residential real estate leases;property management;Machinery and Equipment Leasing;Car rental;Landscaping engineering construction;Import and export;Technology Import and Export;Grain Purchase;Purchase of primary agricultural products;Chinese herbal medicine acquisition.Limited to branch operations:Veterinary drug production;Disinfectant production(Free of Hazardous Chemicals);feed production;Feed additive production;Primary processing of non-edible agricultural products;fertilizer production;Manufacturing of bio-based materials.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Crist��lia Produtos Qu��micos Farmac��uticos Ltda. develops and manufactures pharmaceutical products. It offers its products for algology, primary care practice, dermatology, geriatrics, gynecology, neurology, oncology, orthopedics, psychiatry, rheumatology and urology. The company was founded in 1972 and is headquartered in Itapira, Brazil.

Zhengzhou Houyi Pharmaceutical Co. Ltd. is a Chinese private company located in Zhengzhou that manufactures veterinary drugs.

Heilongjiang Zhicheng Pharmaceutical Technology Co., Ltd., established on 2002-10-18, Business scope includes general items:Biochemical product technology research and development;Production of Chinese herbal extracts;Chemical product production(No licensed chemical products);Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Intellectual Property Services(Except for patent agency services).

Nanchang Lijian Pharmaceutical Co., Ltd., established on 2002-08-26, The business scope includes powder injection(Cephalosporins,AWire,BWire),ointment,cream(Hormone,non hormonal),oral solution,tablet,gel,Powder,hard capsule,dry suspension,Granules,Class II Psychotropic Drug Preparations(Compound codeine phosphate solution)production,Sales;Self-operated and agent import and export of various commodities and technologies.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)(<Foreign Investment Negative List>It is forbidden to invest in the steaming of traditional Chinese medicine decoction pieces,saute,broil,The application of calcining and other processing technologies and the production of secret prescription products of Chinese patent medicines)

Ascelia Pharma AB engages in the research and development of pharmaceutical products for the treatment of cancer and cancer-related diseases. It offers the following clinical stage product candidates: Mangoral, a liver imaging drug being developed for detection and localization of potential liver metastases; and Oncoral, a tablet-based formulation of the chemotherapeutic agent irinotecan, intended for the treatment of advanced gastric cancer. The company was founded on May 17, 1999 and is headquartered in Malmö, Sweden.

Boehringer Ingelheim Animal Health USA, Inc. manufactures biological vaccines for animals. The firm specializes in pharmaceuticals for cattle, equine, pet, and swine. The company was founded by Albrecht Boehringer in 1885 and is headquartered in Duluth, GA.

Yinchuan Shanghetu New Technology R&D Co., Ltd., established on 2013-10-28, Business scope includes research and development of practical new technologies;Research and development of high-tech popularization methods;Research and development of new educational methods;Health products,Food and its quality preservation technology,Research and Development of Fresh Fruit and Vegetable Preservation Technology;Food and dried and fresh fruit packaging sales;Production and sales of plastic packaging containers.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Taihe Biotech Pharmaceutical Co., Ltd. (Taihe) is a biotechnology new drug development company that specializes in the development of a niche market with its own technology platform for its existing pharmaceutical products (Specialty Pharma) . Taihe adheres to the spirit of sincerity, credit and responsibility, carries out product development, and strictly abides by the latest international regulations to carry out all research and development work. It is expected that the product inspection materials established will meet the requirements of advanced countries, in order to facilitate future entry into the international market and authorization. The international large-scale factory carried out follow-up development and obtained the drug certificate of the target drug in the shortest time. It is hoped that Gengyitai will be synthesized as a “ TDS New Drug Development Company ” and establish a Taiwan drug development industry value chain and success stories.

Sichuan Jianneng Pharmaceutical Co., Ltd., established on 2003-12-19, Business scope includes production and sales:tablet,tincture(Including external use),syrup,hard capsule,lotion,API(Sodium chloride,potassium bromide,potassium chloride,Ammonium bromide,magnesium sulfate,boric acid,iodine,potassium iodate,Sodium Bromide)mixture,Suspension,oral solution preparation,Liniment,emulsion,Glycerin agent,gel(external use),Granules,Powder,paint,Gargle,Enema;Medical Technology Development,Technology Transfer and Consulting.(The above business scope does not include legal,Projects requiring pre-approval or licensing as required by laws and regulations,Business activities can only be carried out after the post-licensing project is approved by the relevant department)(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)